Skip to main content
IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.379
+0.011 (2.99%)
At close: Dec 20, 2024, 4:00 PM
0.365
-0.014 (-3.75%)
After-hours: Dec 20, 2024, 7:54 PM EST

IGC Pharma Revenue

IGC Pharma had revenue of $412.00K in the quarter ending September 30, 2024, with 41.58% growth. This brings the company's revenue in the last twelve months to $1.18M, down -11.91% year-over-year. In the fiscal year ending March 31, 2024, IGC Pharma had annual revenue of $1.35M with 47.64% growth.

Revenue (ttm)
$1.18M
Revenue Growth
-11.91%
P/S Ratio
22.17
Revenue / Employee
$17,657
Employees
67
Market Cap
29.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.35M434.00K47.64%
Mar 31, 2023911.00K514.00K129.47%
Mar 31, 2022397.00K-501.00K-55.79%
Mar 31, 2021898.00K-3.17M-77.95%
Mar 31, 20204.07M-1.04M-20.41%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IGC News

More News